Recent exceptional positive changes in investment behavior have benefitted Fresenius Medical Care AG &Co KG (NYSE: FMS): positive upside/downside volume developed, the stock’s recent price rise disrupted its longer term downtrend, and the stock rose on very heavy volume.
Fresenius Medical Care AG &Co KG (NYSE: FMS) has benefited from minimal positive changes in fundamentals: significant quarterly earnings acceleration occurred.
In light of these very positive signals we are reviewing our current Overall Rating of B. We would continue to view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
FMS’ future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be an important Value Builder.
Fresenius Medical Care AG &Co KG has a current Value Trend Rating of B (Positive). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Fresenius Medical Care AG &Co KG has a good Appreciation Score of 84 but a neutral Power Rating of 43, producing the Positive Value Trend Rating.
Recent Price Action
Fresenius Medical Care AG &Co KG (NYSE: FMS) stock enjoyed a large increase of 4.5% on 9/13/24. The stock closed at $21.09. Moreover, this advance was accompanied by exceptionally high trading volume at 365% of normal. The stock has performed in line with the market over the last nine months and has risen 6.4% during the last week.
Be the first to comment